Kaitlyn D’Onofrio

DocwireNews

Inflammatory arthritis (IA) patients often experience fatigue; 41% to 51% of <a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/work-loss-is-still-a-significant-problem-for-rheumatoid-arthritis-patients-starting-therapy-with-methotrexate/">rheumatoid arthritis (RA)</a>, <a href="https://www.docwirenews.com/rheumatology/joint-and-skin-symptoms-make-quality-of-life-significantly-worse-for-psoriatic-arthritis-patients/">psoriatic arthritis (PsA)</a>, and axial <a href="https://www.docwirenews.com/rheumatology/ixekizumab-safely-spondyloarthritis/">spondyloarthritis (axSpA)</a> patients suffer from severe fatigue. Patients with these rheumatic diseases who are plagued by fatigue may suffer in several domains, including quality of life, work impairment, depression, and more, according to a new study.
“Fatigue is considered a multidimensional and complex phenomenon and is found to be associated with pain, sleep problems and low physical activity. Also, severe fatigue has been found to predict depression, low physical activity and quality of life, and more healthcare utilization,” the researchers wrote. “On the other hand, depression, reduced illness beliefs, psychological distress and low self-efficacy have been found to contribute to fatigue. There is limited literature on the correlation between disease-specific and socioeconomic factors.”
RA, PsA, and axSpA patients in Denmark were recruited at an outpatient rheumatology clinic and invited to fill out a survey including disease characteristics, socioeconomic factors, and patient-reported outcomes (PROs)—measured using the FACIT-Fatigue sub-scale, Work Productivity and Activity Impairment scale (WPAI), EuroQol (EQ-5D), Medical Outcomes Study Sleep Scale (MOS), Major Depression Inventory (MDI), and Health Assessment Questionnaire (HAQ).
Final analysis included 487 patients with RA (n=292; 60%), axSpA (n=110; 23%), and PsA (n=85; 17%). The mean age was 53.4 years, and most of the cohort was female (62%). The overall mean fatigue score was 34.4; when measured by disease, it was 34.9 in the RA group, 34.8 in the axSpA group, and 31.8 in the PsA group. The following factors were associated with fatigue:
<ul>
<li>Female sex</li>
<li>Being a more experienced patient</li>
<li>12-month history of changing medications</li>
<li>Unemployment</li>
<li>Less education</li>
<li>Lower household income</li>
</ul>
Fatigue was correlated with all PROs, adversely impacting work, quality of life, sleep, depression, physical functioning, and pain. No significant associations were observed between type of IA, age, or current treatment and fatigue.
The study was published in <a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0237117">PLOS ONE</a>.
“People with IA report fatigue as a key issue that rheumatologists frequently overlook, and consequently patients often believe they should accept fatigue as a part of their condition. However, based on the complexity of fatigue as we identified, rheumatologists and other health professionals instead need not only to be aware of the impact of fatigue on the individual patient’s life, but also to focus their care specifically on the relationship of fatigue with other aspects of the patient’s everyday life,” the researchers wrote. They concluded that fatigue is not a single problem but “a symptom that broadly affects the lives of people with IA.”

Emily Menendez

Non-Invasive NETseq Classifier Determines NET Diagnosis With High Accuracy, Sensitivity

GEP-NETs

High Tumor Mutational Burden Linked to Worse OS, RFS in Patients with HCC

Hepatocellular Carcinoma

Cecilia Brown

IASLC and LCRF Award Team Science Grant for Work on Immune-Based Approaches to Target Drug-Resistant Lung Cancer Cells

Lung Cancer

Latest News

Fatigue Significantly Impacts Numerous Aspects of Life in Patients with RA, AxSpA, PsA

Psoriatic Arthritis

Inflammatory arthritis (IA) patients often experience fatigue; 41% to 51% of rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA) patients ...

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe